Highlights
- KFSHRC’s Biobank modernization will enhance personalized treatments, improving patient outcomes for diseases like cancer and cardiovascular conditions.
- The upgraded Biobank will facilitate groundbreaking research and strengthen Saudi Arabia’s position as a global leader in medical advancements.
- The modernization supports Saudi Vision 2030 goals, focusing on healthcare innovation, sustainability, and improving public health outcomes.
King Faisal Specialist Hospital & Research Center (KFSHRC) has announced the modernization of its Biobank Center, marking a significant milestone in healthcare and medical research within the Kingdom. This modernization aligns with the healthcare goals of Saudi Vision 2030, which emphasize prevention, public health, innovation, and the long-term sustainability of medical research. The Biobank Center aims to accelerate advancements in personalized medicine, improve patient outcomes, and foster novel research and academic excellence.
Dr. Björn Zoëga, Deputy CEO of KFSHRC, stated: “The modernization of the KFSHRC Biobank reflects our commitment to medical innovation and research excellence. By integrating advanced technologies, we aim to position Saudi Arabia as a global leader in personalized medicine and novel healthcare solutions.”
Dr. Amal Qattan, a KFSHRC molecular oncology scientist, highlights that the Biobank stands out in the Kingdom for its advanced specifications and capabilities. This modernization underscores KFSHRC’s dedication to tackling the complexities of modern diseases while promoting innovation in personalized, preventive, predictive, and participatory care.
The Biobank Center is designed to store 10 million high-quality biospecimens, which include liquid biopsies, fresh tissue, and blood derivatives. These samples are managed through a robust and integrated system that safeguards patient information and disease data within secure electronic systems. The infrastructure supports clinical research and advancements in personalized medicine, enabling more patients to benefit from targeted therapies.
The modernized Biobank Center will also enhance healthcare quality and monitor future occurrences of complex diseases such as cancer, cardiovascular conditions, neurological disorders, ageing-related issues, diabetes, and rare diseases. The Biobank protects patient rights and privacy by adhering to rigorous governance structures while considering stakeholder interests.
KFSHRC has achieved remarkable recognition by being ranked 20th globally on the list of the world’s top 250 academic medical centers for the second consecutive year. Newsweek magazine recognized KFSHRC among the world’s best 250 hospitals and included it in the World’s Best Smart Hospitals list for 2025.
Note: This news release was originally published by the King Faisal Specialist Hospital & Research Center (KFSHRC). As it has been republished, it may deviate from our style guide.
About the Author
Biobanking.com delivers valuable news and information on biobanking, biorepositories, cryopreservation, and sample/biospecimen management, while connects buyers with top vendors globally.
